18
Dec
Christina Ochsenbauer and John Kappes at the University of Alabama, Birmingham. a distally related retroviral SIV Env protein boost can increase pre-existing NAb responses against HIV-1. Keywords: Other animals, AIDS, antibodies, vaccination Introduction The high antigenic variability of HIV-1 is one of the major problems in the development of an effective HIV-1 vaccine. However, even HIV-1 has its Achilles heel, since segments of the virus cannot be changed without deleterious consequences for viral replication (1). Accordingly, studies have revealed that 10C30% of HIV-1 infected individuals develop broad serum NAb activity and that a small fraction (approximately 1%) develop very potent…